[English] 日本語
Yorodumi- PDB-2ic3: Crystal Structure of K103N/Y181C Mutant HIV-1 Reverse Transcripta... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 2ic3 | ||||||
|---|---|---|---|---|---|---|---|
| Title | Crystal Structure of K103N/Y181C Mutant HIV-1 Reverse Transcriptase (RT) in Complex with Nonnucleoside Inhibitor HBY 097 | ||||||
Components |
| ||||||
Keywords | TRANSFERASE / RT / NNRTI / NONNUCLEOSIDE INHIBITOR / DRUG RESISTANCE / HIV / AIDS / DRUG DESIGN | ||||||
| Function / homology | Function and homology informationHIV-1 retropepsin / symbiont-mediated activation of host apoptosis / retroviral ribonuclease H / exoribonuclease H / exoribonuclease H activity / host multivesicular body / DNA integration / viral genome integration into host DNA / RNA-directed DNA polymerase / establishment of integrated proviral latency ...HIV-1 retropepsin / symbiont-mediated activation of host apoptosis / retroviral ribonuclease H / exoribonuclease H / exoribonuclease H activity / host multivesicular body / DNA integration / viral genome integration into host DNA / RNA-directed DNA polymerase / establishment of integrated proviral latency / viral penetration into host nucleus / RNA stem-loop binding / RNA-directed DNA polymerase activity / RNA-DNA hybrid ribonuclease activity / Transferases; Transferring phosphorus-containing groups; Nucleotidyltransferases / host cell / viral nucleocapsid / DNA recombination / DNA-directed DNA polymerase / aspartic-type endopeptidase activity / Hydrolases; Acting on ester bonds / DNA-directed DNA polymerase activity / symbiont-mediated suppression of host gene expression / viral translational frameshifting / lipid binding / symbiont entry into host cell / host cell nucleus / host cell plasma membrane / virion membrane / structural molecule activity / proteolysis / DNA binding / zinc ion binding / membrane Similarity search - Function | ||||||
| Biological species | Human immunodeficiency virus type 1 BH10 | ||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 3 Å | ||||||
Authors | Das, K. / Arnold, E. | ||||||
Citation | Journal: J.Mol.Biol. / Year: 2007Title: Crystal Structures of Clinically Relevant Lys103Asn/Tyr181Cys Double Mutant HIV-1 Reverse Transcriptase in Complexes with ATP and Non-nucleoside Inhibitor HBY 097. Authors: Das, K. / Sarafianos, S.G. / Clark, A.D. / Boyer, P.L. / Hughes, S.H. / Arnold, E. #1: Journal: Structure / Year: 1996Title: Structure of Unliganded HIV-1 Reverse Transcriptase at 2.7 A Resolution: Implications of Conformational Changes for Polymerization and Inhibition Mechanisms Authors: Hsiou, Y. / Ding, J. / Das, K. / D Clark, A. / Hughes, S.H. / Arnold, E. #2: Journal: J.Mol.Biol. / Year: 1996Title: Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. Authors: Das, K. / Ding, J. / Hsiou, Y. / Clark, A.D. / Moereels, H. / Koymans, L. / Andries, K. / Pauwels, R. / Janssen, P.A. / Boyer, P.L. / Clark, P. / Smith, R.H. / Kroeger Smith, M.B. / ...Authors: Das, K. / Ding, J. / Hsiou, Y. / Clark, A.D. / Moereels, H. / Koymans, L. / Andries, K. / Pauwels, R. / Janssen, P.A. / Boyer, P.L. / Clark, P. / Smith, R.H. / Kroeger Smith, M.B. / Michejda, C.J. / Hughes, S.H. / Arnold, E. #3: Journal: J.Mol.Biol. / Year: 1998Title: Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance. Authors: Hsiou, Y. / Das, K. / Ding, J. / Clark, A.D. / Kleim, J.P. / Winkler, I. / Riess, G. / Hughes, S.H. / Arnold, E. #4: Journal: J.Mol.Biol. / Year: 2001Title: The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance. Authors: Hsiou, Y. / Ding, J. / Das, K. / Clark, A.D. / Boyer, P.L. / Lewi, P. / Janssen, P.A. / Kleim, J.P. / Hughes, S.H. / Arnold, E. #5: Journal: J.Med.Chem. / Year: 2004Title: Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent ...Title: Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. Authors: Das, K. / Clark, A.D. / Lewi, P.J. / Heeres, J. / De Jonge, M.R. / Koymans, L.M. / Vinkers, H.M. / Daeyaert, F. / Ludovici, D.W. / Kukla, M.J. / De Corte, B. / Kavash, R.W. / Ho, C.Y. / Ye, ...Authors: Das, K. / Clark, A.D. / Lewi, P.J. / Heeres, J. / De Jonge, M.R. / Koymans, L.M. / Vinkers, H.M. / Daeyaert, F. / Ludovici, D.W. / Kukla, M.J. / De Corte, B. / Kavash, R.W. / Ho, C.Y. / Ye, H. / Lichtenstein, M.A. / Andries, K. / Pauwels, R. / Boyer, P.L. / Clark, P. / Hughes, S.H. / Janssen, P.A. / Arnold, E. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 2ic3.cif.gz | 212 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb2ic3.ent.gz | 167.6 KB | Display | PDB format |
| PDBx/mmJSON format | 2ic3.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 2ic3_validation.pdf.gz | 803.5 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 2ic3_full_validation.pdf.gz | 889.1 KB | Display | |
| Data in XML | 2ic3_validation.xml.gz | 48.1 KB | Display | |
| Data in CIF | 2ic3_validation.cif.gz | 64.5 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/ic/2ic3 ftp://data.pdbj.org/pub/pdb/validation_reports/ic/2ic3 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 2iajC ![]() 1s6qS C: citing same article ( S: Starting model for refinement |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
| ||||||||
| Details | HETERODIMER of p66 and p51 subunits |
-
Components
| #1: Protein | Mass: 64425.855 Da / Num. of mol.: 1 / Fragment: p66 / Mutation: C280S Source method: isolated from a genetically manipulated source Source: (gene. exp.) Human immunodeficiency virus type 1 BH10Genus: Lentivirus / Species: Human immunodeficiency virus 1 / Strain: BH10 ISOLATE / Gene: pol / Production host: ![]() |
|---|---|
| #2: Protein | Mass: 51970.562 Da / Num. of mol.: 1 / Fragment: p51 / Mutation: C280S Source method: isolated from a genetically manipulated source Source: (gene. exp.) Human immunodeficiency virus type 1 BH10Genus: Lentivirus / Species: Human immunodeficiency virus 1 / Strain: BH10 ISOLATE / Gene: pol / Production host: ![]() |
| #3: Chemical | ChemComp-MN / |
| #4: Chemical | ChemComp-HBY / ( |
| #5: Water | ChemComp-HOH / |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 3.22 Å3/Da / Density % sol: 61.75 % |
|---|---|
| Crystal grow | Temperature: 277 K / Method: vapor diffusion, hanging drop / pH: 6.8 Details: PEG 8000, BIS_TRIS PROPANE, AMMONIUM SULFATE, GLYCEROL, MNCL2, HBY 097, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K |
-Data collection
| Diffraction | Mean temperature: 100 K | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: APS / Beamline: 14-BM-C / Wavelength: 1 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Detector | Type: ADSC QUANTUM 4 / Detector: CCD / Date: Oct 12, 2000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Radiation | Monochromator: GRAPHITE / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reflection | Resolution: 3→40 Å / Num. obs: 26685 / % possible obs: 90.1 % / Observed criterion σ(I): -1 / Redundancy: 3.4 % / Rmerge(I) obs: 0.046 / Χ2: 1.184 / Net I/σ(I): 24.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reflection shell |
|
-
Processing
| Software |
| ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 1S6Q Resolution: 3→19.9 Å / Rfactor Rfree error: 0.009 / Data cutoff high absF: 645411.812 / Data cutoff low absF: 0 / Isotropic thermal model: RESTRAINED / Cross valid method: THROUGHOUT / σ(F): 1 / Stereochemistry target values: Engh & Huber
| ||||||||||||||||||||||||||||
| Solvent computation | Solvent model: FLAT MODEL / Bsol: 29.852 Å2 / ksol: 0.232 e/Å3 | ||||||||||||||||||||||||||||
| Displacement parameters | Biso mean: 87.6 Å2
| ||||||||||||||||||||||||||||
| Refine analyze |
| ||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 3→19.9 Å
| ||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||
| LS refinement shell | Resolution: 3→3.19 Å / Rfactor Rfree error: 0.035 / Total num. of bins used: 6
| ||||||||||||||||||||||||||||
| Xplor file |
|
Movie
Controller
About Yorodumi



Human immunodeficiency virus type 1 BH10
X-RAY DIFFRACTION
Citation
















PDBj








